NCT05232877

Brief Summary

Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique using a low intensity electric current to modify cortical excitability. Apathy is a pervasive neuropsychiatric symptom characterized by a reduction in goal-directed behavior and activity that persists over time and causes identifiable functional impairment. The aim of this study is to evaluate the effects of repeated sessions of tDCS combined with simultaneous cognitive training on apathy in older people with minor neurocognitive disorders.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for not_applicable

Timeline
1mo left

Started Apr 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Apr 2022Jun 2026

First Submitted

Initial submission to the registry

December 21, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 10, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

April 5, 2022

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 4, 2025

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2026

Expected
Last Updated

November 26, 2025

Status Verified

November 1, 2025

Enrollment Period

3 years

First QC Date

December 21, 2021

Last Update Submit

November 25, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Apathy Inventory (Robert et al., 2002), clinician version

    The Apathy Inventory scored from 0 (No problem) to 4 (major problem) the 3 dimensions of apathy: the emotional blunting, the loss of initiative and the loss of interest. A higher total score indicates a greater severity.

    Changes from baseline severity of apathy at 4 weeks and 18 weeks are assessed (12 weeks after the end of intervention)

Secondary Outcomes (12)

  • Assessment of neuropsychiatric symptoms

    Changes from baseline severity of apathy at 4 weeks and 18 weeks are assessed (12 weeks after the end of intervention)

  • Assessment of the global cognitive functioning

    Changes from baseline severity of apathy at 4 weeks and 18 weeks are assessed (12 weeks after the end of intervention)

  • Assessment of cognitive functions with FAB

    Changes from baseline severity of apathy at 4 weeks and 18 weeks are assessed (12 weeks after the end of intervention)

  • Assessment of episodic memory

    Changes from baseline severity of apathy at 4 weeks and 18 weeks are assessed (12 weeks after the end of intervention)

  • Assessment of attention and mental flexibilty

    Changes from baseline severity of apathy at 4 weeks and 18 weeks are assessed (12 weeks after the end of intervention)

  • +7 more secondary outcomes

Study Arms (2)

tDCS combined with simultaneous cognitive training

EXPERIMENTAL
Other: tDCS

cognitive training with a combined sham tDCS

SHAM COMPARATOR
Other: SHAM tDCS

Interventions

The control group will follow cognitive training with a combined sham tDCS. Intervention will last for 4-week with 3 sessions per week (12 sessions).

cognitive training with a combined sham tDCS
tDCSOTHER

The intervention group will follow sessions of tDCS combined with a simultaneous cognitive training on tablet

tDCS combined with simultaneous cognitive training

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age ≥ 65 years
  • Subject consulting in one of the investigating centers
  • Clinical diagnosis of Minor Neurocognitive Disorder according to DSM 5 criteria (APA, 2013)
  • Apathetic syndrome defined according to the Diagnostic Criteria for Apathy (Miller \& al., 2021)
  • Subject who can read and write French
  • Subjects who are beneficiaries of a social security plan
  • Signature of free and informed consent

You may not qualify if:

  • Current clinical diagnosis of a depressive episode characterized by DSM 5 criteria (APA, 2013)
  • Known diagnosis of schizophrenia, bipolar disorder, substance abuse or dependence
  • Significant sensory or motor impairment
  • Subject under guardianship, conservatorship, or conservatorship
  • Active smoking or smoking cessation of less than one year
  • Contraindications to the practice of tDCS: history of intracranial hypertension, neurosurgery, metallic implant at the cephalic level, pacemaker
  • Unbalanced epilepsy
  • Severe somatic disease not stabilized
  • Previous use of tDCS (problem of maintaining the integrity of the blinding procedure)
  • Scalp skin disease
  • Concurrent participation in another drug research study or any other study that may interfere with study results

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Memoire Ressources et Recherche, CHU de Nice

Nice, 06000, France

Location

MeSH Terms

Conditions

LethargyNeurocognitive Disorders

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Eric ETTORE, MD

    Nice University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The intervention group will follow sessions of tDCS combined with a simultaneous cognitive training on tablet. he control group will follow cognitive training with a combined sham tDCS. Intervention will last for 4-week with 3 sessions per week (12 sessions).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 21, 2021

First Posted

February 10, 2022

Study Start

April 5, 2022

Primary Completion

April 4, 2025

Study Completion (Estimated)

June 10, 2026

Last Updated

November 26, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations